Ventura Cannabis and Wellness Corp CVHIF

Healthcare Drug Manufacturers - Specialty & Generic

Ventura Cannabis and Wellness Corp is a vertically integrated, California-based products cannabis company. The company is currently building out its distribution channel through revenue-sharing agreements with owner-operator of cannabis dispensaries to ensure it's products get premium shelf space. The Company plans to target four segments in the U.S. cannabis and CBD market with products suited to their needs: senior citizens, upwardly mobile middle-aged female professionals, upwardly mobile middle-aged male professionals and individuals suffering from addiction.

GREY:CVHIF - Post by User

Ventura Cannabis and Wellness Corp

Bullboard Posts

Comment by Xiawen13on Sep 29, 2016 1:58pm

159 Views

Post# 25291578

RE:BIG SALE 350,000 SHARES DUMPED AT BID TODAY

hi Choices

On Aug 2nd , CEO issued a press release estmating Q3 editda margins would be 25% thanks to staff cut, not in spite of it. That is an estimate from an insider well aware of the recent situation. Exaclty the opposite of you

now you can speculate that revenu will move in opposite direction than the number of facilities added during Q1 (san diego, portland...) because you spoke to a staff to whom you ask what is the slow period in your line of business, but it seems an argument a little too thin to sell my shares:-)

choices999 wrote: Hello Everyone,

I guess that everyone if finally realizing that this business model is not working.

We have proof that people are laid off, only one is called back and by the sound of the email it refers to being called back with a salary cut.

Having a salary cut means disgruntled employees and it also infers that sales must be dismal to resort to these measures.

What is most alarming is that conversation was recent at of mid September so things look like they are not recovering, possibly even deteriorating.

I noted a huge sale of 350,000 shares done at the bid price, which hardly inspires confidence.

Also a check on level 2 shows only 950,000 shares to buy compared to 1.1 million to sale.

One big sell order and it will eat up all of the bids.

The bidders are refusing to pay the asking price.

PHM is also down.

If we compare valuations of CXV to PHM then CXV should trade at 60% of sales.

Sales for CXV will probably be $ 25 million per year at best. I would not be surprised to see it much lower.

At $ 25 million it means a valuation of $ 15 million if we use PHM comparatives.

A $ 15 million valuation means a stock of 6.6 cents at best.

We can`t use the cash on back to value stock since business model is not really profitable. One quarter out of four is not a profitable model.

This is my personal opinion, you are free to disagree.

The trading tells the tale, it appears most agree to my position.